Aberdeen Group’s Harpoon Therapeutics HARP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-25,991
Closed -$296K – 985
2023
Q4
$296K Buy
+25,991
New +$204K ﹤0.01% 913

Aberdeen Group's HARP Position: Q1 2024 in Review

Aberdeen Group sold out of Harpoon Therapeutics (HARP) in Q1 2024, closing a stake of 25,991 shares — an estimated $296K sold.

Aberdeen Group first reported a position in HARP in Q4 2023 and held it in 1 quarter. The position peaked at $296K in Q4 2023. 0 funds tracked by Wall St. Rank hold HARP as of Q1 2024.

  • Aberdeen Group reported no remaining Harpoon Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Aberdeen Group sold 25,991 Harpoon Therapeutics shares in Q1 2024, an estimated $296K.
  • Aberdeen Group first reported a position in Harpoon Therapeutics in Q4 2023 and held it in 1 quarter.
  • Aberdeen Group's Harpoon Therapeutics position peaked at $296K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Harpoon Therapeutics as of Q1 2024.

Based on Aberdeen Group's 13F filing for Q1 2024, filed 9 May 2024.